ClinicalTrials.gg
Active, not recruitingNCT02199054Updated Apr 20, 2026

Functional Snack Foods With Safflower Oil and Soy in Postmenopausal Women Having Metabolic Syndrome

An interventional study of wheat-safflower oil pretzels and soy-safflower oil pretzels in Metabolic Syndrome and Overweight, sponsored by Ohio State University. Active, not recruiting at 1 site in United States. Open to female participants aged 45 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-04-20.

Sponsored by Ohio State University · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
45 Years to 70 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Metabolic Syndrome by Ohio State University — 1 open to participants now, 2 under way, none of them phase 3. Metabolic Syndrome · Ohio State University.

Planned enrollment
8th of 10
20 · median 38
Started
2014
with 1 other
No phase
10 of 10
1 open now
Registered
3rd of 10
by date

Among the 10 studies in Metabolic Syndrome by Ohio State University, this one is the 8th largest by planned enrollment, is one of 2 that started in 2014, is one of 10 with no phase, and was the 3rd registered.

Metabolic Syndrome

2,119 studies on the registry are indexed under Metabolic Syndrome; 350 are open to participants now.

Browse Metabolic Syndrome studies →

Open to participants now

1 of the 10 studies in Metabolic Syndrome by Ohio State University is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 234 Metabolic Syndrome studies recruiting now, 70 (30%) set no upper age limit and 135 (58%) stop at 75 or younger; 20 take children under 18; 81 take healthy volunteers.

This study: 45 Years to 70 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Metabolic Syndrome by Ohio State University, or all of them as a file.
02

Study summary

This research study is being done to help researchers develop new dietary options for menopausal women to maintain a healthy weight by developing more nutritious snacks that have health benefits. From this study, the researchers hope to gain understanding on how menopausal women with metabolic syndrome digest and absorb foods with safflower oil on its own and when combined with soy. The research team hypothesize that the two different types of pretzels may be processed by your body differently and that components in the pretzel snacks may be helpful for preventing diseases like obesity and cancer. Safflower oil and soybeans contain many natural chemicals that may benefit human health. However, this relationship is not well understood. This study will look at the impact of the pretzel snacks on your blood fat and glucose levels as well as a group of chemicals found in soy called "isoflavones". Isoflavones are natural chemicals found commonly in soybeans or foods made from them.

Participants will be screened to determine if they qualify in meeting the study requirements. Participants cannot have a known allergy to dairy, soy, safflower oil, or wheat protein. Also, participants will be asked to stop eating legumes (beans, peas, soy protein, sprouts and peanuts) and to document the oils they eat for the entire 14 weeks of this study. The study will require five visits to the Ohio State University Clinical Research Center (CRC) which part of the Ohio State University's Center for Clinical and Translational Sciences. Once the investigators have determined that you qualify for this study and you decide to participate, you will be consuming three different pretzels each for one month, starting with a control pretzel. After the control pretzel treatment period, you will be randomly assigned (like the "flip of a coin") to start with one of the two pretzel groups (wheat or soy pretzel with safflower oil) for your first treatment period and then switch to the other safflower oil pretzel at your second treatment period.

Read the detailed description

The overarching goal is to develop new dietary strategies to help postmenopausal women maintain a healthy weight by improving the availability of nutritious snacks that contain added health benefits and will be used to assess the impact of a functional snack on snacking behavior. The primary objective is to evaluate safflower oil delivered in a wheat pretzel compared to a wheat pretzel enhanced with soy will have a greater affect on blood triglyceride and glucose levels thereby affecting satiety and snacking behavior. The investigators hypothesize that a functional snack food such as a soft pretzel containing safflower oil either with or without soy compared to the control pretzel (wheat pretzel with no safflower oil) will reduce postprandial blood triglycerides and glucose.

This proposed multidisciplinary study is a randomized cross-over trial involving 20 overweight (BMI > 25 kg/m2) postmenopausal women with metabolic syndrome will participate in a dietary intervention study for a total of 14 weeks (two weeks of washout and three 4 week interventions). The study will require five visits to the Ohio State University Clinical Research Center (CRC), part of the Center for Clinical and Translational Sciences, Figure 5. Women will visit the CRC to be screened (Day-14) and their eligibility will be determined using a health and lifestyle questionnaire and results from a 12 hour fasting lipid panel (total cholesterol, LDL, HDL, triglycerides). Those meeting the National Cholesterol Education Program criteria for metabolic syndrome and having no other excluding conditions will be enrolled. Prior to their oral triglyceride tolerance tests (OTTT), women will be instructed to abstain from a. alcohol consumption for 72 hour, b. consume ≥150g of carbohydrates for 24 hours, c. abstain from vigorous exercise for 24 hours, d. collect urine for 24 hours, e. fast for 12 hours prior to all their clinic visits. When women arrive at the CRC for their clinic visits, weight and vital signs will be collected and a venous catheter placed for timed blood collections. Blood will be collected for serum triglycerides and glucose prior to (-5 minutes) and at 30, 60, 90, 120, 150, 180, 240, 300, and 360 minutes after consumption of the test meal. At their run-in visit (Day 0), subjects will consume a control pretzel with a flavored oil dip containing a standardized quantity of triglycerides (50 g long chain fatty acids). At the first treatment period (Day 28) visit, women will be randomized to one of the two intervention groups (wheat or soy pretzel with safflower oil) and then crossover to the other safflower oil pretzel at their second treatment period visit (Day 56). The two intervention pretzel meals will be accompanied with the same oil dip provided before. At the end of each OTTT visit women will be instructed to continue eating the test pretzels (12 pretzel bites/day) for the next 28 days as a snack. Subjects will be instructed to complete questions pertaining to their satiety during their 7 hour stay. Women will return for their last visit on Day 84 to submit all completed study materials (survey, dietary recall, and daily intake journal), completed 24 hour urine collection, and blood collection.

03

Conditions studied

  • Metabolic Syndrome
  • Overweight

Keywords

  • Snack Foods
  • Safflower Oil
  • Soy
  • Postmenopausal women
  • Metabolic Syndrome
04

Who can participate

Ages eligible
45 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women 45 to 70 years of age
  • Stated to be postmenopausal and has a cessation of menstruation for greater than 12 months
  • Have a ≥25 kg/m2
  • Must meet three of the five following criteria12

    1. Have a waist circumference greater than 35 inches
    2. Fasting serum triglycerides of greater than 150 mg/dL
    3. Fasting high density lipoprotein (HDL) less than 40 mg/dL
    4. Fasting blood glucose greater than 100 mg/dL
    5. Systolic blood pressure greater than 130 mm Hg or diastolic blood pressure greater than 85 mm Hg
  • Agree to consume a standardized vitamin/mineral supplement and avoid other nutrition and alternative supplements for the duration of the study
  • Agree to follow a legume free diet and to document any accidental consumption of restricted foods each day of the study

Exclusion criteria

Exclusion Criteria:

  • Have an active metabolic or digestive illness including malabsorptive disorders, renal insufficiency, hepatic insufficiency, or had recent (within the year) gastrointestinal surgery.
  • Have a history or have active hormone related diseases of the pituitary, thyroid or pancreas that currently require supplemental hormonal administration thyroid hormones, adrenocorticotropic hormone (ACTH), growth hormone or other endocrine disorders requiring hormone or insulin administration
  • Have an active or a recent history of any condition that causes altered immunity such as chronic inflammatory disease, disorders, cancer, anemia, and blood dyscrasias
  • Are on cholesterol lowering medications which include but not limited to statins, niacin (vitamin B3), bile-acid resins, fibric acid derivatives, or cholesterol absorption inhibitors.
  • Have a known allergy or food intolerance to ingredients in study products (wheat, soy, or safflower oil)
  • Are strict vegans (no consumption of animal, fish or egg products)
  • Are heavy alcohol consumers (defined as an average consumption of greater than 14 drinks/week)
  • Have a history of cancer or currently undergoing treatment for cancer
  • Have been on an antibiotic regime lasting for more than one week in the last 6 months
  • Are currently on another study for weight loss or trying to actively lose weight or recently (last 3 months) started medications for weight loss.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Placebo comparator
    Run-in Intervention

    Control wheat pretzel bites (12 pieces total) will be consumed with a flavored oil dip containing a standardized quantity of triglycerides (50 g long chain fatty acids) at the start of a 7 hour clinic visit as well as 6 pieces of control wheat pretzels will be eaten twice a day (total of 12 pieces/day) for 28 days. During these 28 days, participants will monitor their oil consumption and maintain a legume-free diet.

    Other: control wheat pretzels

  • Active comparator
    Wheat-Safflower Oil Arm

    Wheat-safflower oil pretzel bites (12 pieces total) will be consumed with a flavored oil dip containing a standardized quantity of triglycerides (50 g long chain fatty acids) at the start of a 7 hour clinic visit as well as 6 pieces of wheat-safflower oil pretzels will be eaten twice a day (total of 12 pieces/day) for 28 days. During these 28 days, participants will monitor their oil consumption and maintain a legume-free diet.

    Other: wheat-safflower oil pretzels

  • Active comparator
    Soy-Safflower Oil Arm

    Soy-safflower oil pretzel bites (12 pieces total) will be consumed with a flavored oil dip containing a standardized quantity of triglycerides (50 g long chain fatty acids) at the start of a 7 hour clinic visit as well as 6 pieces of soy-safflower oil pretzels will be eaten twice a day (total of 12 pieces/day) for 28 days. During these 28 days, participants will monitor their oil consumption and maintain a legume-free diet.

    Other: soy-safflower oil pretzels

Interventions

  • Otherwheat-safflower oil pretzels

    Each serving (6 pieces) of the wheat-safflower oil pretzel contains 6 grams of safflower oil. Ingredients in the pretzel are high gluten wheat flour, safflower oil, sugar, yeast, salt, and ascorbic acid.

  • Othersoy-safflower oil pretzels

    Each serving (6 pieces) of the soy-safflower oil pretzel contains 6 grams of safflower oil. Ingredients in the pretzel are high gluten wheat flour, soy flour, soymilk, safflower oil, sugar, yeast, salt, and ascorbic acid.

  • Othercontrol wheat pretzels

    Each serving (6 pieces) of the control wheat pretzel contains 6 grams of vegetable shortening. Ingredients in the pretzel are high gluten wheat flour, vegetable shortening, sugar, yeast, salt, and ascorbic acid.

06

What researchers measure

Primary outcomes

  1. Number of Participants having Serious and Non-serious Adverse Events.

    Standardized qualitative and quantitative toxicity criteria (NIH) will be employed to evaluate safety and toxicity of daily safflower oil consumption.

    Time frame: Up to 3 months

  2. Number of Participants with 80% Adherence to Safflower Oil Pretzels

    The daily consumption of safflower oil pretzels with and without soy will be assessed with a daily dietary intake journal as well as with measures of isoflavone and linoleic acid metabolites in urine and blood, respectively.

    Time frame: Up to 3 months

Secondary outcomes

  1. Number of Participants with Improved Satiety Visual Analogue Scale (VAS) with Safflower Oil Pretzel Snacks Compared to Control Pretzels.

    The impact of safflower oil pretzels with and without soy on snacking behavior and satiety will be measured by comparing visual analogue scale surveys, food frequency questionnaires, and total energy intake extracted from 24 hour dietary recalls.

    Time frame: Up to 3 months

  2. Area Under the Concentration-Time Curve for Serum Triglyceride and Glucose

    Postprandial triglycerides and glucose following consumption of a single meal consisting of safflower oil pretzels with or without soy will be compared to a control pretzel having neither safflower oil nor soy.

    Time frame: Before test meal, 30, 60, 90, 120, 150, 180, 240, 300, and 360 minutes after the test meal on Days 0, 28, and 56

Other outcomes

  1. Identify Number of Participants with Changes in Blood Gene Expression from Day 0 Compared to Day 84.

    Impact of safflower oil consumption on gene expression profiles and biomarkers relevant to energy metabolism will be examined and correlated to their isoflavonoid metabolic profile.

    Time frame: Up to 3 months

  2. Isoflavone Metabolite Profile Collected from Urine on Days 0, 28, 56, and 84

    Women will be classified by their isoflavone metabolites in urine and correlated with biological effects of safflower oil pretzel intervention and gene expression

    Time frame: Up to 3 months

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2014 (actual). Primary completion is estimated for Apr 2027, 153 months after the start.

Of 627 non-industry interventional studies with no phase under Metabolic Syndrome, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 41. This study's planned 153 months is above that.

Counting every sponsor, half of 677 studies reached it within 20 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 19, 2014
First posted
Jul 24, 2014
StartActual
Jul 2014
Primary completionEst.
Apr 10, 2027
CompletionEst.
Apr 10, 2027
Last update
Apr 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02199054
Responsible party
Yael Vodovotz (Professor, Ohio State University) — Principal investigator
First posted
Jul 24, 2014
Start date
Jul 2014
Primary completion
Apr 10, 2027 (estimated)
Completion
Apr 10, 2027 (estimated)
Last update
Apr 20, 2026

Study contacts

Yael Vodovotz, Ph.D.
principal investigator · Ohio State University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion